On March 26, 2025, the Apollo Cancer Centre in Hyderabad launched “ColFit”, a comprehensive screening program designed to detect and prevent colorectal cancer (CRC) at an early stage. The initiative aims to improve survival rates, reduce treatment costs, and address the trend of late-stage diagnoses, which lead to poor outcomes and increased healthcare burdens. The ColFit program uses the faecal immunochemical test (FIT), a non-invasive and highly accurate screening tool that identifies hidden blood in stool, a potential early indicator of CRC.
The FIT test is a simple and painless process that involves a small stool sample, which can help detect CRC early, even before symptoms appear. Early detection of CRC can significantly improve treatment outcomes, reduce healthcare costs, and save lives.
The launch of ColFit was attended by senior doctors, including Dr. Ajesh Raj Saksena, GI Surgical Oncologist, and Dr. Raghu DK, Medical Gastroenterologist from Apollo Hospitals. V Tejesvi, CEO of the Telangana region of Apollo Hospitals, was also present at the launch.
ColFit is a significant step towards reducing the incidence of CRC and improving healthcare in the region. It demonstrates Apollo Hospitals’ commitment to providing comprehensive and innovative solutions to address the growing burden of cancer. With ColFit, early detection and prevention of CRC will become more accessible, and people can take proactive steps to protect their health and well-being.